These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31862199)

  • 1. Shedding of oral pentavalent bovine-human reassortant rotavirus vaccine indicates high uptake rate of vaccine and prominence of G-type G1.
    Markkula J; Hemming-Harlo M; Vesikari T
    Vaccine; 2020 Feb; 38(6):1378-1383. PubMed ID: 31862199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring Shedding of Five Genotypes of RotaTeq Vaccine Viruses by Genotype-Specific Real-Time Reverse Transcription-PCR Assays.
    Higashimoto Y; Ihira M; Miyazaki Y; Kuboshiki A; Yoshinaga S; Hiramatsu H; Suzuki R; Miyata M; Miura H; Komoto S; Yukitake J; Taniguchi K; Kawamura Y; Yoshikawa T
    J Clin Microbiol; 2018 Jun; 56(6):. PubMed ID: 29563200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua.
    Bucardo F; Rippinger CM; Svensson L; Patton JT
    Infect Genet Evol; 2012 Aug; 12(6):1282-94. PubMed ID: 22487061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of RotaTeq
    Jeong S; Than VT; Lim I; Kim W
    J Virol Methods; 2016 Nov; 237():72-78. PubMed ID: 27590978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of PCV-2 DNA in stool samples from infants vaccinated with RotaTeq®.
    Esona MD; Mijatovic-Rustempasic S; Yen C; Parashar UD; Gentsch JR; Bowen MD; LaRussa P
    Hum Vaccin Immunother; 2014; 10(1):25-32. PubMed ID: 24104203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination.
    Donato CM; Ch'ng LS; Boniface KF; Crawford NW; Buttery JP; Lyon M; Bishop RF; Kirkwood CD
    J Infect Dis; 2012 Aug; 206(3):377-83. PubMed ID: 22615314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infant immune response to human rotavirus serotype G1 vaccine candidate reassortant WI79-9: different dose response patterns to virus surface proteins VP7 and VP4.
    Clark HF; Lawley D; Shrager D; Jean-Guillaume D; Offit PA; Whang SY; Eiden JJ; Bennett PS; Kaplan KM; Shaw AR
    Pediatr Infect Dis J; 2004 Mar; 23(3):206-11. PubMed ID: 15014293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multivalent Rotavirus Vaccine and Wild-type Rotavirus Strain Shedding in Australian Infants: A Birth Cohort Study.
    Ye S; Whiley DM; Ware RS; Kirkwood CD; Lambert SB; Grimwood K
    Clin Infect Dis; 2018 Apr; 66(9):1411-1418. PubMed ID: 29149283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq.
    Matthijnssens J; Joelsson DB; Warakomski DJ; Zhou T; Mathis PK; van Maanen MH; Ranheim TS; Ciarlet M
    Virology; 2010 Aug; 403(2):111-27. PubMed ID: 20451234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.
    Ciarlet M; Schödel F
    Vaccine; 2009 Dec; 27 Suppl 6():G72-81. PubMed ID: 20006144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Live attenuated tetravalent (G1-G4) bovine-human reassortant rotavirus vaccine (BRV-TV): Randomized, controlled phase III study in Indian infants.
    Saluja T; Palkar S; Misra P; Gupta M; Venugopal P; Sood AK; Dhati RM; Shetty A; Dhaded SM; Agarkhedkar S; Choudhury A; Kumar R; Balasubramanian S; Babji S; Adhikary L; Dupuy M; Chadha SM; Desai F; Kukian D; Patnaik BN; Dhingra MS
    Vaccine; 2017 Jun; 35(28):3575-3581. PubMed ID: 28536027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rotavirus shedding following administration of RV3-BB human neonatal rotavirus vaccine.
    Cowley D; Boniface K; Bogdanovic-Sakran N; Kirkwood CD; Bines JE
    Hum Vaccin Immunother; 2017 Aug; 13(8):1908-1915. PubMed ID: 28481726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of RotaTeq® vaccine-derived rotaviruses in South Korean infants with rotavirus gastroenteritis.
    Than VT; Jeong S; Kim W
    J Med Virol; 2015 Jan; 87(1):112-6. PubMed ID: 24817171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of virus shedding after lived attenuated and pentavalent reassortant rotavirus vaccine.
    Hsieh YC; Wu FT; Hsiung CA; Wu HS; Chang KY; Huang YC
    Vaccine; 2014 Feb; 32(10):1199-204. PubMed ID: 24076325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rotavirus shedding in premature infants following first immunization.
    Smith CK; McNeal MM; Meyer NR; Haase S; Dekker CL
    Vaccine; 2011 Oct; 29(45):8141-6. PubMed ID: 21856359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.
    Vesikari T; Clark HF; Offit PA; Dallas MJ; DiStefano DJ; Goveia MG; Ward RL; Schödel F; Karvonen A; Drummond JE; DiNubile MJ; Heaton PM
    Vaccine; 2006 May; 24(22):4821-9. PubMed ID: 16621194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rotavirus genotypes and clinical outcome of natural infection based on vaccination status in the post-vaccine era.
    Kozawa K; Higashimoto Y; Kawamura Y; Miura H; Negishi T; Hattori F; Ihira M; Komoto S; Taniguchi K; Yoshikawa T
    Hum Vaccin Immunother; 2022 Dec; 18(1):2037983. PubMed ID: 35240934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequence analysis of VP7 and VP4 genes of G1P[8] rotaviruses circulating among diarrhoeic children in Pune, India: a comparison with Rotarix and RotaTeq vaccine strains.
    Kulkarni R; Arora R; Arora R; Chitambar SD
    Vaccine; 2014 Aug; 32 Suppl 1():A75-83. PubMed ID: 25091685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulation.
    Clark HF; Burke CJ; Volkin DB; Offit P; Ward RL; Bresee JS; Dennehy P; Gooch WM; Malacaman E; Matson D; Walter E; Watson B; Krah DL; Dallas MJ; Schödel F; Kaplan kM; Heaton P
    Pediatr Infect Dis J; 2003 Oct; 22(10):914-20. PubMed ID: 14551493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rotavirus epidemiology 5-6 years after universal rotavirus vaccination: persistent rotavirus activity in older children and elderly.
    Markkula J; Hemming-Harlo M; Salminen MT; Savolainen-Kopra C; Pirhonen J; Al-Hello H; Vesikari T
    Infect Dis (Lond); 2017 May; 49(5):388-395. PubMed ID: 28067093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.